Shares of Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) fell 34.4% during mid-day trading on Monday . The company traded as low as GBX 5 ($0.06) and last traded at GBX 5.74 ($0.07). 224,450 shares changed hands during mid-day trading, a decline of 13% from the average session volume of 258,339 shares. The stock had previously closed at GBX 8.75 ($0.11).
Celadon Pharmaceuticals Stock Down 30.1 %
The company has a debt-to-equity ratio of 196.67, a current ratio of 1.92 and a quick ratio of 6.97. The company has a 50 day moving average price of GBX 17.23 and a 200-day moving average price of GBX 21.44. The stock has a market capitalization of £3.75 million, a PE ratio of -0.77 and a beta of -0.26.
Celadon Pharmaceuticals Company Profile
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines. Its primary focus is on improving quality of life for chronic pain sufferers, as well as exploring the potential of cannabis-based medicines for other conditions such as autism.
Recommended Stories
- Five stocks we like better than Celadon Pharmaceuticals
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Profitably Trade Stocks at 52-Week Highs
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Investing In Preferred Stock vs. Common Stock
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
